Condition: Lymphangioleiomyomatosis · Sponsor: University of Cincinnati
The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR inhibitors (sirolimus or everolimus) as part of their clinical care. Adult female TSC patients may also enroll, with or without lung cysts.
This description comes directly from the study's public registry record.
Susan McMahan Sellers, BSN, RN · (513) 558-4376 · susan.mcmahan@uc.edu
Francis X McCormack, MD · (513) 558-0588 · frank.mccormack@uc.edu
Always discuss trial participation with your own doctor first.
| Stanford University Medical Center | Stanford, California, United States | Recruiting |
| National Jewish Health | Denver, Colorado, United States | Recruiting |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Emory University School of Medicine | Atlanta, Georgia, United States | Recruiting |
| Loyola University Medical Center, Chicago | Maywood, Illinois, United States | Active Not Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Mayo Clinic Rochester | Rochester, Minnesota, United States | Active Not Recruiting |
| Washington University School of Medicine | St Louis, Missouri, United States | Recruiting |
| University of Rochester Medical Center | Rochester, New York, United States | Recruiting |
| University of Cincinnati | Cincinnati, Ohio, United States | Active Not Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Active Not Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02432560